CAH vs CPHI · P/E 35, rev $222.58B vs rev $4.1M
Cardinal Health Inc (CAH) versus China Pharma Holdings Inc (CPHI) — a side-by-side from cached financials, not a winner call.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CAH revenue for 2025-06-30 was $222.58B. Net income was $1.57B. Revenue was down 1.9% from 2024-06-30 to 2025-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
CAH currently screens at market cap $53.00B and trailing P/E 34.6. CPHI currently screens at market cap $29.0M.
Not investment advice. Open the CAH and CPHI stock pages for the full models.
Not investment advice.